CardioNerds
CardioNerds
Cardionerds is an entertaining and educational medical cardiology podcast created by three cardiologists. They want to bring high yield cardiovascular concepts in a fun and engaging format for their listeners of all levels. Click below to learn more!
Advertisement
CardioNerdsCardioNerds | June 13, 2024
The CardioNerds and Dr. Alexander discuss the findings of the ATTRibute-CM clinical trial.
View More
CardioNerdsCardioNerds | June 13, 2024
The CardioNerds and Dr. Alexander analyze biomarkers in ATTR-CM.
CardioNerdsCardioNerds | June 13, 2024
The CardioNerds and Dr. Kevin M. Alexander discuss the nuances of transthyretin amyloid cardiomyopathy.
Amit Goyal, MDCardioNerds | June 10, 2024
Treatment-related early increase in serum transthyretin levels are associated with reduced CV-related hospitalizations.
Amit Goyal, MDCardioNerds | June 10, 2024
A study uncovered surprising findings regarding the presence and nature of transthyretin in stenotic aortic valves.
Amit Goyal, MDCardioNerds | June 10, 2024
A study investigated the prevalence and implications of ATTR-CA across different heart failure phenotypes.
Amit Goyal, MDCardioNerds | June 10, 2024
A case series explored the impact of possessing more than 1 pathogenic variant of the TTR gene on the severity of ATTR.
Amit Goyal, MDISA 2024 | June 10, 2024
A study underscores the importance of NT-proBNP as a biomarker in stratifying disease severity in ATTR-CA.
CardioNerdsLipid Management | May 31, 2024
The CardioNerds and colleagues address the topic of familial hypercholesterolemia.
CardioNerdsCardioNerds | May 20, 2024
The CardioNerds conference scholars discuss the upcoming Critical Care Cardiology Education Summit.
CardioNerdsHeart Failure Guidelines | March 13, 2024
The CardioNerds and expert faculty Dr. Harriette Van Spall discuss palliative care's role in patients with heart failure.
CardioNerdsHeart Failure Guidelines | February 14, 2024
The CardioNerds and expert faculty Dr. Javed Butler discuss the best next step for a patient with cardiogenic shock.
Amit Goyal, MDInterventional Cardiology | January 4, 2024
Intravascular imaging to guide PCI improves hard clinical end points.
Amit Goyal, MDCardioNerds | January 11, 2024
A meta-analysis found that peri-device leak on transesophageal echocardiography is both common and dangerous.
Amit Goyal, MDCardioNerds | December 21, 2023
Ticagrelor monotherapy after dual-antiplatelet therapy following PCI with DES yields superior outcomes.
Dr. Cali ClarkInterventional Cardiology | November 28, 2023
Dr. Clark details the MINT trial, which addressed the accurate transfusion threshold in patients with acute MI and anemia.
Dr. Nazli OkumusInterventional Cardiology | November 28, 2023
Dr. Okumus details the ORBITA-2 trial, which marked a significant advancement in understanding and treating stable angina.
Dr. Ahmed GhoneemCardioNerds | November 20, 2023
CardioNerds correspondent Dr. Ahmed Ghoneem details the positive effects of semaglutide, as demonstrated in the SELECT trial.
Dr. Christian InchausteguiCardioNerds | November 20, 2023
CardioNerds correspondent Dr. Christian Inchaustegui details the findings of ARIES-HM3, presented at AHA 2023.
Amit Goyal, MDCardioNerds | November 2, 2023
In low-risk patients with symptomatic AS, TAVR is safe, effective, and durable up to 5 years.
Advertisement
Advertisement
Advertisement
Latest News

June 21, 2024